Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.

Bonegio RG, Lin JD, Beaudette-Zlatanova B, York MR, Menn-Josephy H, Yasuda K.

J Immunol. 2019 Feb 1;202(3):675-683. doi: 10.4049/jimmunol.1800300. Epub 2019 Jan 4.

PMID:
30610165
2.

Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Wang Z, Salih E, Igwebuike C, Mulhern R, Bonegio RG, Havasi A, Borkan SC.

J Am Soc Nephrol. 2019 Jan;30(1):50-62. doi: 10.1681/ASN.2018040401.

PMID:
30573638
3.

Editorial: Podocytes as Active Participants in Lupus Nephritis.

Rifkin IR, Bonegio RG.

Arthritis Rheumatol. 2017 Aug;69(8):1517-1520. doi: 10.1002/art.40157. Epub 2017 Jun 30. No abstract available.

4.

TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.

Bossaller L, Christ A, Pelka K, Nündel K, Chiang PI, Pang C, Mishra N, Busto P, Bonegio RG, Schmidt RE, Latz E, Marshak-Rothstein A.

J Immunol. 2016 Aug 15;197(4):1044-53. doi: 10.4049/jimmunol.1501943. Epub 2016 Jun 27.

5.

Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.

Al-Rabadi L, Ayalon R, Bonegio RG, Ballard JE, Fujii AM, Henderson JM, Salant DJ, Beck LH Jr.

Am J Kidney Dis. 2016 May;67(5):775-8. doi: 10.1053/j.ajkd.2015.10.031. Epub 2015 Dec 29.

6.

Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Duffau P, Menn-Josephy H, Cuda CM, Dominguez S, Aprahamian TR, Watkins AA, Yasuda K, Monach P, Lafyatis R, Rice LM, Kenneth Haines G 3rd, Gravallese EM, Baum R, Richez C, Perlman H, Bonegio RG, Rifkin IR.

Arthritis Rheumatol. 2015 Dec;67(12):3146-57. doi: 10.1002/art.39321.

7.

IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.

Watkins AA, Yasuda K, Wilson GE, Aprahamian T, Xie Y, Maganto-Garcia E, Shukla P, Oberlander L, Laskow B, Menn-Josephy H, Wu Y, Duffau P, Fried SK, Lichtman AH, Bonegio RG, Rifkin IR.

J Immunol. 2015 Feb 15;194(4):1467-79. doi: 10.4049/jimmunol.1402807. Epub 2015 Jan 16.

8.

Conditional knockout of proximal tubule mitofusin 2 accelerates recovery and improves survival after renal ischemia.

Gall JM, Wang Z, Bonegio RG, Havasi A, Liesa M, Vemula P, Borkan SC.

J Am Soc Nephrol. 2015 May;26(5):1092-102. doi: 10.1681/ASN.2014010126. Epub 2014 Sep 8.

9.

Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.

Yasuda K, Watkins AA, Kochar GS, Wilson GE, Laskow B, Richez C, Bonegio RG, Rifkin IR.

PLoS One. 2014 Jul 30;9(7):e103478. doi: 10.1371/journal.pone.0103478. eCollection 2014.

10.

Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosus.

Watkins AA, Bonegio RG, Rifkin IR.

Methods Mol Biol. 2014;1169:143-58. doi: 10.1007/978-1-4939-0882-0_14.

PMID:
24957237
11.

Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus.

Aprahamian TR, Bonegio RG, Weitzner Z, Gharakhanian R, Rifkin IR.

Immunology. 2014 Jul;142(3):363-73. doi: 10.1111/imm.12256.

12.

Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

Yasuda K, Nündel K, Watkins AA, Dhawan T, Bonegio RG, Ubellacker JM, Marshak-Rothstein A, Rifkin IR.

Int Immunol. 2013 May;25(5):295-306. doi: 10.1093/intimm/dxs114. Epub 2013 Jan 4.

13.

Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration.

Havasi A, Haegele JA, Gall JM, Blackmon S, Ichimura T, Bonegio RG, Panchenko MV.

Am J Pathol. 2013 Jan;182(1):152-62. doi: 10.1016/j.ajpath.2012.09.017. Epub 2012 Nov 14.

14.

Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure.

Fan X, Li Q, Pisarek-Horowitz A, Rasouly HM, Wang X, Bonegio RG, Wang H, McLaughlin M, Mangos S, Kalluri R, Holzman LB, Drummond IA, Brown D, Salant DJ, Lu W.

Cell Rep. 2012 Jul 26;2(1):52-61. doi: 10.1016/j.celrep.2012.06.002. Epub 2012 Jul 12.

15.

Role of mitofusin 2 in the renal stress response.

Gall JM, Wang Z, Liesa M, Molina A, Havasi A, Schwartz JH, Shirihai O, Borkan SC, Bonegio RG.

PLoS One. 2012;7(1):e31074. doi: 10.1371/journal.pone.0031074. Epub 2012 Jan 26.

16.

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ.

J Am Soc Nephrol. 2011 Aug;22(8):1543-50. doi: 10.1681/ASN.2010111125. Epub 2011 Jul 22.

17.

Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress.

Gall JM, Wong V, Pimental DR, Havasi A, Wang Z, Pastorino JG, Bonegio RG, Schwartz JH, Borkan SC.

Kidney Int. 2011 Jun;79(11):1207-16. doi: 10.1038/ki.2010.532. Epub 2011 Mar 23.

18.

The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development.

Bonegio RG, Beck LH, Kahlon RK, Lu W, Salant DJ.

Kidney Int. 2011 May;79(10):1099-112. doi: 10.1038/ki.2010.553. Epub 2011 Jan 26.

19.

Induction of heat shock protein 70 inhibits ischemic renal injury.

Wang Z, Gall JM, Bonegio RG, Havasi A, Hunt CR, Sherman MY, Schwartz JH, Borkan SC.

Kidney Int. 2011 Apr;79(8):861-70. doi: 10.1038/ki.2010.527. Epub 2011 Jan 26.

20.

IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR.

J Immunol. 2010 Jan 15;184(2):796-806. doi: 10.4049/jimmunol.0901748. Epub 2009 Dec 9.

21.

Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.

Yasuda K, Richez C, Uccellini MB, Richards RJ, Bonegio RG, Akira S, Monestier M, Corley RB, Viglianti GA, Marshak-Rothstein A, Rifkin IR.

J Immunol. 2009 Sep 1;183(5):3109-17. doi: 10.4049/jimmunol.0900399. Epub 2009 Jul 31.

22.

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ.

N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.

23.

The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.

Aprahamian T, Bonegio RG, Richez C, Yasuda K, Chiang LK, Sato K, Walsh K, Rifkin IR.

J Immunol. 2009 Jan 1;182(1):340-6.

24.

A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.

Bonegio RG, Fuhro R, Ragno G, Robert Valeri C, Lieberthal W.

Artif Cells Blood Substit Immobil Biotechnol. 2006;34(2):145-57.

PMID:
16537171
25.

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

Bonegio RG, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, Lieberthal W.

J Am Soc Nephrol. 2005 Jul;16(7):2063-72. Epub 2005 May 25.

26.

Circadian temperature rhythm blunting and sleep composition.

Bonegio RG, Driver HS, King LM, Laburn HP, Shapiro CM.

Acta Physiol Scand Suppl. 1988;574:44-7.

PMID:
3245467

Supplemental Content

Loading ...
Support Center